Roth Capital Has Bearish Outlook for Tilray FY2025 Earnings

Tilray Inc (NASDAQ:TLRY - Free Report) - Equities research analysts at Roth Capital cut their FY2025 earnings estimates for Tilray in a report released on Monday, April 7th. Roth Capital analyst W. Kirk now expects that the company will post earnings per share of ($0.24) for the year, down from their previous forecast of ($0.23). The consensus estimate for Tilray's current full-year earnings is ($0.20) per share.

A number of other research firms have also recently commented on TLRY. Canaccord Genuity Group increased their price target on Tilray from $2.00 to $3.00 and gave the company a "buy" rating in a research note on Monday, January 13th. Piper Sandler decreased their price objective on shares of Tilray from $2.00 to $1.00 and set a "neutral" rating for the company in a research report on Wednesday.

Tilray Stock Down 3.6 %

Shares of TLRY traded down $0.02 during midday trading on Wednesday, hitting $0.49. 22,827,649 shares of the company's stock traded hands, compared to its average volume of 29,463,982. Tilray has a 1 year low of $0.44 and a 1 year high of $2.52. The firm's fifty day moving average is $0.73 and its 200-day moving average is $1.17. The company has a current ratio of 2.54, a quick ratio of 1.58 and a debt-to-equity ratio of 0.10. The stock has a market capitalization of $457.01 million, a price-to-earnings ratio of -1.62 and a beta of 1.88.

Tilray (NASDAQ:TLRY - Get Free Report) last posted its earnings results on Tuesday, April 8th. The company reported ($0.10) EPS for the quarter, missing analysts' consensus estimates of ($0.04) by ($0.06). Tilray had a negative net margin of 30.95% and a negative return on equity of 4.40%. The firm had revenue of $185.78 million for the quarter, compared to analysts' expectations of $213.38 million.

Remove Ads

Hedge Funds Weigh In On Tilray

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the company. California State Teachers Retirement System increased its holdings in shares of Tilray by 8.0% in the fourth quarter. California State Teachers Retirement System now owns 778,513 shares of the company's stock valued at $1,035,000 after purchasing an additional 57,544 shares during the period. Wealth Enhancement Advisory Services LLC increased its holdings in Tilray by 317.7% in the 4th quarter. Wealth Enhancement Advisory Services LLC now owns 166,326 shares of the company's stock worth $221,000 after buying an additional 126,507 shares during the period. Toronto Dominion Bank increased its holdings in Tilray by 53.0% in the 4th quarter. Toronto Dominion Bank now owns 197,207 shares of the company's stock worth $260,000 after buying an additional 68,284 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its position in Tilray by 17.1% during the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 1,964,380 shares of the company's stock worth $2,613,000 after buying an additional 286,481 shares during the last quarter. Finally, Two Sigma Advisers LP lifted its stake in Tilray by 81.7% during the 4th quarter. Two Sigma Advisers LP now owns 164,800 shares of the company's stock valued at $219,000 after acquiring an additional 74,100 shares during the period. Hedge funds and other institutional investors own 9.35% of the company's stock.

Tilray Company Profile

Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Canada.